PLoS ONE (Jan 2012)

Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown.

  • Katharina Kurz,
  • Michael Fiegl,
  • Bernhard Holzner,
  • Johannes Giesinger,
  • Marianna Pircher,
  • Guenter Weiss,
  • Hubert A Denz,
  • Dietmar Fuchs

DOI
https://doi.org/10.1371/journal.pone.0036956
Journal volume & issue
Vol. 7, no. 5
p. e36956

Abstract

Read online

BACKGROUND: Patients with cancer often suffer from fatigue and decreased quality of life which might be related to the breakdown of essential amino acid tryptophan. METHODS: In 50 patients with lung cancer we examined fatigue and the deterioration of quality of life in patients using the Functional Assessment of Cancer Therapy Anemia (FACT-An) and -Fatigue (FACT-F) subscales of FACT-General and the Mental adjustment to Cancer (MAC) questionnaires. Results were compared with tryptophan breakdown as well as serum concentrations of immune activation markers. RESULTS: Scores of psychological tests correlated significantly with tryptophan breakdown and with circulatory markers of inflammation. However, immune activation and tryptophan breakdown were not related to MAC scores. CONCLUSIONS: Tryptophan breakdown relates with fatigue and impaired quality of life in patients with lung cancer, while declining tryptophan levels are not associated with patients'coping strategies.